← Back to Search

Behavioral Intervention

Virtual Reality for Exercise Performance

N/A
Recruiting
Led By Andrew R Moore, PhD
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Women who are pregnant at the time of participation according to a pregnancy test.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed during the exercise test for each condition.
Awards & highlights

Summary

"This trial aims to see if using virtual reality during a exercise test affects how well healthy adults perform. They want to know if virtual reality changes the maximum aerobic capacity and work rate during exercise. Participants will

Who is the study for?
This trial is for healthy adults interested in how virtual reality might affect their performance during a maximal aerobic exercise test. Participants will need to be able to perform strenuous exercise and commit to two testing sessions with a week of recovery in between.
What is being tested?
The study is examining if using virtual reality videos while doing an intense workout can change the highest amount of oxygen someone can use (VO2peak) or when they hit the ventilatory threshold, which is a point during exercise where breathing starts to get really heavy.
What are the potential side effects?
Since this trial involves standard physical tests under lab conditions and watching virtual reality videos, side effects may include typical exercise-related discomfort or motion sickness due to VR.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not pregnant according to a pregnancy test.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed during the exercise test for each condition.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed during the exercise test for each condition. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
VO2peak
Ventilatory threshold
Secondary outcome measures
%VO2peak at ventilatory threshold
Affective Valence
Heart rate at VO2peak
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Virtual Reality condition completed firstExperimental Treatment2 Interventions
In this arm, the Virtual Reality condition (traditional maximal cardiorespiratory exercise test with the addition of virtual reality video) will be completed first, and the Control condition (traditional maximal cardiorespiratory exercise test) will be completed second.
Group II: Control condition completed firstExperimental Treatment2 Interventions
In this arm, the Control condition (traditional maximal cardiorespiratory exercise test) will be completed first, and the Virtual Reality condition (traditional maximal cardiorespiratory exercise test with the addition of virtual reality video) will be completed second.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Control condition
2010
Completed Phase 4
~10520

Find a Location

Who is running the clinical trial?

Augusta UniversityLead Sponsor
213 Previous Clinical Trials
85,088 Total Patients Enrolled
Andrew R Moore, PhDPrincipal InvestigatorAugusta University
~0 spots leftby Oct 2024